GleamWall
中文EN

ARWR ARROWHEAD PHARMACEUTICALS, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 879407 · Fiscal year ends 09/30

Financial factors as of 2026-09-30 (2026Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-45.6%
TTM net income YoY-44,302.3%
TTM EPS YoY-51,000.0%
Revenue 3-yr CAGR23.3%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-156.9%
Net margin-160.6%
FCF margin-63.0%
EBITDA margin-151.4%

Returns

ROE-280.5%
ROA-46.4%
ROIC (approx.)-492.0%
Asset turnover0.29x

Leverage & solvency

Liabilities / assets97.1%
Debt / equity0.00x
Current ratio4.14x
Interest coverage-7.55x

Cash quality & payout

Operating cash flow / net income0.38x
Accruals ratio-29.0%
Payout ratio—
Capex / revenue2.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-09-30FY20252025-09-30
Income statement
Revenue$450.82M$829.45M
R&D expense$739.14M$607.16M
SG&A expense$202.04M$123.94M
Operating income-$707.17M$98.35M
Interest expense$93.71M$89.36M
Pretax income-$723.91M$51.53M
Income tax-$6.78M$21.42M
Net income-$724.21M-$1.63M
EBITDA-$682.47M$120.55M
EPS (basic)-5.11-0.01
EPS (diluted)-5.11-0.01
Weighted avg. shares (diluted)141.63M133.76M
Balance sheet
Cash & equivalents$62.73M$226.55M
Short-term investments$1.13B$692.82M
Receivables$9.93M$6.82M
Inventory$9.07M$0
Current assets$1.29B$950.64M
PP&E, net$371.31M$382.51M
Intangibles$5.16M$6.86M
Total assets$1.74B$1.39B
Current liabilities$311.34M$195.49M
Total liabilities$1.69B$881.88M
Shareholders' equity$50.31M$466.05M
Shares outstanding141.29M135.70M
Cash flow statement
Operating cash flow-$271.95M$179.55M
Capital expenditure$11.99M$22.67M
Free cash flow-$283.94M$156.89M
Investing cash flow-$670.48M-$129.29M
Financing cash flow$776.82M$74.01M
Depreciation & amortization$24.70M$22.20M
Stock-based compensation$68.15M$63.37M

Free plan shows the latest 2 periods; Pro shows all 24 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.